New research reveals that patients who come off blockbuster weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass far faster than those who stop conventional lifestyle programs.
Findings released in a major health publication shows that while obese people often shed substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying such drugs need to be cognizant of the risk of quick rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.
That rate of regain implies a return to original mass in about 18 months.
Comparing Approaches
The analysis, which examined dozens of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with other pills.
Researchers emphasize that people who lose weight through lifestyle changes alone typically experience a more gradual creep back—approximately 100 grams monthly—post-intervention.
The Reason for the Quick Rebound
Experts believe the mechanism of the jabs is key to understanding the heightened rebound.
These medications mimic a body's own chemical called GLP-1, which controls hunger.
"Sustained high doses of the hormone concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement leads to hunger is uncontrolled, making binge eating far more likely."
An Ongoing Condition?
The NHS suggest the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, considering the significant potential of relapse, the therapy might need to be long-term.
This view is echoed by drug manufacturers, who state that the findings "underscore the long-term character of obesity," akin to managing conditions like hypertension.
Patient Testimonies
Individuals who have discontinued the jabs explain a sudden return of hunger.
"It was like a trigger activating and I was suddenly extremely hungry," recalled an individual.
This difficulty is exacerbated if individuals have not established permanent lifestyle or habit changes during therapy.
Widespread Interest
Survey data show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is more common among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, experts emphasize that while the jabs are potent tools for weight loss, they are not a magic solution and maintained weight loss hinges on integrated behavioural support.